title: Erlotinib in symptomatic brain metastases from a lung adenocarcinoma with a sensitizing EGFR mutation.
authors.affiliation: Núcleo de Oncologia Torácica (NOT), Clínicas Oncológicas Integradas (COI) and Instituto COI (ICOI), Rio de Janeiro, Brazil. luizaraujo@coinet.com.br
authors.forename: Luiz H
authors.initials: LH
authors.lastname: de Lima Araújo
authors.forename: Juliana S
authors.initials: JS
authors.lastname: da Silveira
authors.forename: Clarissa S
authors.initials: CS
authors.lastname: Baldotto
authors.forename: Mauro
authors.initials: M
authors.lastname: Zukin
authors.forename: Carlos G
authors.initials: CG
authors.lastname: Ferreira
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology*; D000077192:Adenocarcinoma of Lung; D000368:Aged; D001706:Biopsy; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D004273:DNA, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D000069347:Erlotinib Hydrochloride; D005091:Exons; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D009154:Mutation / Q000187:drug effects*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D004273:DNA, Neoplasm; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors